Brundavan Laboratories Private Limited - Charges

Every charge - open or closed - that lenders have registered against Brundavan Laboratories Private Limited, with the most recent activity a…

2002-12-19 Hyderabad, Telangana Active Unlisted Active Compliant
Share
Connect MCP
BL Brundavan Laboratories Private Limited
Open charges
1
30.65 cr
Closed charges
2
3.86 cr
Total
3
34.51 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Axis Bank Limited 1 30.65 cr
2 Syndicate Bank 2 3.86 cr
All charges (3) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
10621021 Axis Bank Limited 24 Dec 2015 08 Sep 2022 - 30.65 cr Open
10020545 Syndicate Bank 24 Aug 2006 02 Jul 2014 25 Jan 2016 2.22 cr Closed
90259059 Syndicate Bank 03 Feb 2005 - 25 Jan 2016 1.64 cr Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Brundavan Laboratories Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Brundavan Laboratories Private Limited (CIN: U24231TG2002PTC040136). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Brundavan Laboratories Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.